Invention Grant
- Patent Title: Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
-
Application No.: US15160593Application Date: 2016-05-20
-
Publication No.: US09808422B2Publication Date: 2017-11-07
- Inventor: Irene Pasquali , Rossella Musa , Francesca Schiaretti , Azita Askey-Sarvar
- Applicant: CHIESI FARMACEUTICI S.p.A.
- Applicant Address: IT Parma
- Assignee: Chiesi Farmaceutici S.p.A.
- Current Assignee: Chiesi Farmaceutici S.p.A.
- Current Assignee Address: IT Parma
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: EP13176114 20130711; EP13194763 20131128
- Main IPC: A61K9/14
- IPC: A61K9/14 ; A61K9/00 ; A61K31/167 ; A61K31/573 ; A61K31/40 ; A61K45/06 ; A61J3/02 ; A61M15/00
Abstract:
Dry powder formulations for inhalation comprising a combination of an anticholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of inflammatory and/or obstructive airways diseases.
Public/Granted literature
Information query
